I agree that this site is using cookies. You can find further informations here.
X
Mateos, Maria‐Victoria
610  results:
Search for persons X
?
1

Comparative Efficacy of Talquetamab vs. Current Treatments ..:

Einsele, Hermann ; Moreau, Philippe ; Bahlis, Nizar...
Advances in Therapy.  41 (2024)  4 - p. 1576-1593 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Recent Developments in Convenience of Administration of the..:

Quach, Hang ; Parmar, Gurdeep ; Mateos, Maria-Victoria..
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  6 - p. 358-363 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Prevalence and Consequences of a Delayed Diagnosis in Multi..:

Negrete-Rodríguez, Paola ; Gallardo-Pérez, Moisés Manuel ; Lira-Lara, Olivia...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  7 - p. 478-483 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Health-related quality of life in relapsed/refractory multi..:

Schjesvold, Fredrik H. ; Ludwig, Heinz ; Delimpasi, Sossana...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
5

Daratumumab for patients with myeloma with early or late re..:

Spencer, Andrew ; Moreau, Philippe ; Mateos, Maria-Victoria...
Blood Advances.  8 (2024)  2 - p. 388-398 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Impact of prior treatment on selinexor, bortezomib, dexamet..:

Mateos, Maria‐Victoria ; Engelhardt, Monika ; Leleu, Xavier...
European Journal of Haematology.  113 (2024)  2 - p. 242-252 , 2024
Link: https://doi.org/10.1111/..
 
?
7

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibi..:

Díaz-Tejedor, Andrea ; Rodríguez-Ubreva, Javier ; Ciudad, Laura...
International Journal of Molecular Sciences.  25 (2024)  9 - p. 4718 , 2024
Link: https://doi.org/10.3390/..
 
?
8

A research center's experience of T-cell–redirecting therap..:

Puertas, Borja ; Fernández-Sánchez, Adolfo ; Alejo, Elena...
Blood Advances.  8 (2024)  13 - p. 3478-3487 , 2024
Link: https://doi.org/10.1182/..
 
?
9

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiv..:

Ludwig, Heinz ; Ramasamy, Karthik ; Mateos, María-Victoria...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. e40-e49.e3 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. 194-202 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Safety and efficacy of belantamab mafodotin with pembrolizu..:

Suvannasankha, Attaya ; Bahlis, Nizar ; Trudel, Suzanne...
Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
12

An open‐label, first‐in‐human, single agent, dose escalatio..:

Kapoor, Prashant ; Nathwani, Nitya ; Jelinek, Tomas...
European Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
13

Selinexor, daratumumab, bortezomib and dexamethasone for th..:

González-Calle, Verónica ; Rodríguez-Otero, Paula ; Sureda, Anna...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
14

Characterization and Outcomes of Spanish Patients With Rela..:

Mateos, Maria-Victoria ; Weisel, Katja ; Diels, Joris...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  4 - p. 224-231.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Multiple Myeloma:

, In: The EBMT Handbook,
Mohty, Mohamad ; Bruno, Benedetto ; Gagelmann, Nico. - p. 741-749 , 2024
Link: https://doi.org/10.1007/..
 
1-15